Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm

In response to the coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), global efforts are focused on the development of new therapeutic interventions. For the treatment of COVID-19, selective lung-localizing strategies hold tremendous po...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nano Today
Egile Nagusiak: Kim, Hyelim, Lee, Han Sol, Ahn, June Hong, Hong, Kyung Soo, Jang, Jong Geol, An, Jiseon, Mun, Yong-Hyeon, Yoo, So-Yeol, Choi, Yoon Jung, Yun, Mi-Young, Song, Gyu Yong, Joo, Jinmyoung, Na, Dong Hee, Kim, Hong Nam, Park, Hee Ho, Lee, Jae-Young, Lee, Wonhwa
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Author(s). Published by Elsevier Ltd. 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8026257/
https://ncbi.nlm.nih.gov/pubmed/33846686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nantod.2021.101149
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak